PLOD2 is an independent prognostic marker and molecular mediator in glioblastoma

Authors :: Kreße, N
Schröder, H
Stein, KP
Mawrin, C
Dumitru, CA
Sandalcioglu, IE
Source :: 73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie; 20220529-20220601; Köln; DOCV076 /20220525/
Publication Year :: 2022
Publisher :: German Medical Science GMS Publishing House, 2022.
Abstract: Objective: Glioblastoma (GBM) is the most common form of malignant primary brain tumour. Only a dismal proportion of GBM patients achieve 5-year survival. Thus, it is critical to identify novel prognostic markers and molecular mechanisms, which could serve as targets for novel therapeutic strategies [for full text, please go to the a.m. URL]

Language :: English
Database :: OpenAIRE
Journal :: 73. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Griechischen Gesellschaft für Neurochirurgie; 20220529-20220601; Köln; DOCV076 /20220525/
Accession number :: edsair.doi.dedup.....fc6e7c1a2d3f1661b769903d52ea4a3f
Full Text :: https://doi.org/10.3205/22dgnc080

Full Text Access

Tools